论文部分内容阅读
观察59例原发性高脂血症患者服用小剂量吉非罗齐8周的疗效,显示小剂量古非罗齐能使胆固醇(TC)和甘油三酯(TG)的水平降低20%和53%,高密度脂蛋白胆固醇(HDL-C)的水平升高17%;治疗高甘油三酯血症、高胆固醇血症和高密度脂质缺乏症的总有效率分别为93%、68%和62%,虽较常规剂量组的疗效偏低,但其副作用却较少.
To observe the curative effect of low-dose gefitinzole in 59 patients with primary hyperlipidemia for 8 weeks, it was shown that low-dose of gefilozil reduced the levels of cholesterol (TC) and triglyceride (TG) by 20% and 53 %, High-density lipoprotein cholesterol (HDL-C) levels increased by 17%; treatment of hypertriglyceridemia, hypercholesterolemia and high-density lipid deficiency, the total effective rate was 93%, 68% and 62%, although less effective than the conventional dose group, but fewer side effects.